Document is current
Any future updates will be listed below
-
Authors
St. Pierre, Michelle https://orcid.org/0000-0002-4522-3166
Argento, Elena
Cates, Jordyn
Kryskow, Pamela
Harvey, Kalin
Stamets, Paul
Santos-Brault, Eesmyal
Paschall, Sarah A.
Kuypers, Kim P.C.
Rootman, Joseph
Walsh, Zach
-
Funding
Funding for this research was provided by:
Mitacs (Mitacs, Mitacs)
- License Information
-
More Information
Article History
Received: 10 March 2025
Accepted: 10 September 2025
First Online: 11 October 2025
Declarations
:
: This study was approved by the University of British Columbia Research Ethics Board (H19-03051).
: All participants provided written informed consent prior to participating.
: Not applicable.
: Michelle St. Pierre has received research funding through a Mitacs post-doctoral fellowship in partnership with MycoMedica Life Sciences PBC who are involved in the development of psychedelic treatments. Elena Argento is a part-time consultant to psychedelic company Numinus Wellness Inc. Joseph Rootman and Jordyn Cates have received research funding from a partnership between Mitacs and Quantified Citizen Technologies who provided the data collection platform for this study. Pamela Kryskow is a member of the clinical advisory board of Numinus Wellness which is a company that provides psychedelic psychotherapy services. Pamela Kryskow is compensated for this role with Numinus stock. Kalin Harvey is the CTO and co-founder of Quantified Citizen which is a company that produces software for decentralized mobile research, which was used in this study. Sarah Paschall is a former employee of Quantified Citizen which is a company that produces software for decentralized mobile research, which was used in this study. Paul Stamets is a minority investor in Quantified Citizen a co-founder of MycoMedica Life Sciences, PBC and is an applicant on patents using psilocybin mushrooms, Lion’s mane mushrooms and/or niacin. Eesmyal Santos-Brault is the CEO and co-founder of Quantified Citizen which is a company that produces software for decentralized mobile research, which was used in this study. Zach Walsh is in paid relationships with Numinus Wellness, EntheoTech Biomedical, Quantified Citizen and Mycomedica Life Sciences regarding consulting, education and provision of clinical services related to the medical development and application of psychedelics.
